Recent News

• 05.13.2025 - Absci First Quarter 2025 Business Update and Financial and Operating Results Conference Call
• 05.13.2025 - Absci First Quarter 2025 Business Update and Financial and Operating Results Conference Call
• 04.14.2025 - Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025
• 04.14.2025 - Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025
• 04.08.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.08.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.02.2025 - H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference
• 04.02.2025 - H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference
• 03.26.2025 - Absci to Participate in Upcoming Investor Conferences
• 03.26.2025 - Absci to Participate in Upcoming Investor Conferences

Recent Filings

• 04.11.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 04.10.2025 - EFFECT Notice of Effectiveness
• 04.01.2025 - S-3 Registration statement under Securities Act of 1933
• 03.18.2025 - EX-99.1 EX-99.1